Surgical management of abdominal manifestations of type 1 neurofibromatosis: Experience of a single center

American Surgeon

Volumn 76, Issue 4, 2010, Pages 389-396

  Cavallaro, Giuseppe ^a   Basile, Ursula ^a   Polistena, Andrea ^a   Giustini, Sandra ^a   Arena, Rossella ^a   Scorsi, Alessandro ^a   Zinnamosca, Laura ^a   Letizia, Claudio ^a   Calvieri, Stefano ^a   De Toma, Giorgio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALECTOMY; ADULT; AGED; ARTICLE; CARCINOID; CLINICAL ARTICLE; CLINICAL FEATURE; COLON TUMOR; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EMBRYONAL TISSUE; FEMALE; GANGLIONEUROMA; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TUMOR; GENETIC SCREENING; HUMAN; JEJUNUM TUMOR; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; NERVE SHEATH TUMOR; NEUROENDOCRINE TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; NEUROGENIC TUMOR; PHEOCHROMOCYTOMA; RETROPERITONEAL TUMOR;

ABDOMINAL NEOPLASMS; ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 1; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PHEOCHROMOCYTOMA; RETROPERITONEAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77950412515     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Huson SM, Compston DAS, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. Prevalence, fitness, mutation rate and effect of parental transmission on severity. J Med Genet 1989;26:704-711
2. Fallace MR, Marchuk DA, Anderson LB, et al. Type 1 neurofibromatosis gene: identification of a larger transcript disrupted in three NG1 patients. Science 1990;249:181-186
3. Xu GF, O'Connel P, Viskochil D, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62: 599-608.
4. Visckochil D, Buchberg AN, Xu G, et al. Deletions and a traslocation interrupt a clone gene at the neurofibromatosis type 1 locus. Cell 1990;62:1887-1892
5. Friedma JM, Riccardi VM. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 3rd ed. Baltimore: John Hopkins University Press; 1999.
6. National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Arch Neurol 1988;45: 575-578
7. Gutmann DH, Aylsworth A, Carely JC, et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278: 51-57
8. Huson SM, Harper PS, Compston DAS. von Recklinghausen neurofibromatosis 1: clinical and population study in South East Wales. Brain 1988;111:55-81.
9. Lubs ML, Bauer MS, Formas ME, Djoic B. Lisch nodules in neurofibromatosis type 1. N Engl J Med 1991;324:1264-1266
10. Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis type 1: consensus statement from theNf1 optic pathway glioma study. Ann Neurol 1997;41:143-149
11. Listernick R, Ferner RE, Piersal L, et al. Late onset optic pathway tumours in children with neurofibromatosis type 1. Neurology 2004;63:1944-1946
12. Crawford AH Jr, Bagamery N. Osseus manifestation of neurofibromatosis in childhood. J Pediatr Orthop 1986;6: 72-88.
13. Kuoriletho T, Poyhonen M, Bloigu R, et al. Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load carrying parts of the body. Osteoporos Int 2005;16:928-936
14. North KN, Riccardi V, Samango Sprouse C, et al. Cognitive function and academic performance in neurofibromatosis 1: consensus statement from the Nf1. Cognitive Disorder Task Force. Neurology 1997;48:1121-1127
15. Friedman JM, Arbiser J, Epstein JA, et al. Cardiovascular disease in neurofibromatosis 1: a report of the NF1 Cardiovascular Task Force. Genet Med 2003;4:105-111
16. Messiaen LM, Callens T, Mortier G, et al. Exhaustive mutation analysis of the Nf1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat 2000;14:541-555
17. Tonsgard JH, Yelavarthi KK, Cushner S, et al. Do Nf1 gene deletions result in a characteristic phenotype? Am J Med Genet 1997;73:80-86
18. De Raedt T, Brems H,Wolkenstein P, et al. Elevated risk for MPNST in Nf1 microdeletions patients. Am J Hum Genet 2003;72: 1288-1292
19. Verlinsky Y, Rechitsky S, Verlinsky O, et al. Preimplantation diagnosis for neurofibromatosis. Reprod Biomed Online 2002;4:218-222
20. Levy AD, Patel N, Dow N, et al. From the archives of the AFIP: abdominal neoplasm in patients with neurofibromatosis type 1: radiologic-pathologic correlation. Radiographics 2005;25: 455-480
21. Scheithauer BW, Woodruff JM, Erlandson RA. Tumours of the Peripheral Nervous System. Washington, DC: Armed Forces Institute of Pathology; 1999.
22. Miettinen M, Kopczynski J, Makhulouf HR, et al. Gastrointestinal stromal tumours, intramural leiomyomas and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, andmolecular genetic study of 167 cases.Am J Surg Pathol 2003;27: 625-641
23. Ghrist TD. Gastrointestinal involvement in neurofibromatosis. Arch Intern Med 1963;112:357-362
24. Kinoshita K, Hirota S, Isozaki K, et al. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol 2004;202:80-85
25. Hayflick SJ, Hofmann KJ, Tunnesen WW, et al. Neurofibromatosis 1: recognition and management of associated neuroblastoma. Pediatr Dermatol 1990;7:293-295
26. Costi R, Caruana P, Sarli L, et al. Ampullary adenocarcinoma in neurofibromatosis type 1: case reported in literature review. Mod Pathos 2001;14:1169-1174
27. Scheithauer BW, Woodruff JM, Erlandson RA. Tumours of the Peripheral Nervous System. Washington, DC: Armed Forces Institute of Pathology; 1999.
28. Riccardi VM. Neurofibromatosis: Phenotype, Natural History and Pathogenesis, 2nd ed. Baltimore: John Hopkins University Press; 1992.
29. Petersen JM, Ferguson DR. Gastrointestinal neurofibromatosis. J Clin Gastroenterol 1984;6:529-534
30. Fukuy T, Lu CC, Mitros FA. CT findings of plexiform neurofibromatosis involving the ileum and its mesentery. Clin Imaging 1994;18:142-145
31. Bass JC, Korobkin M, Francio IR, et al. Retroperitoneal plexiform neurofibromas: CT findings. AJR Am J Roentgenol 1994;163:617-620
32. Ros PR, Eshaghi N. Plexiform neurofibroma of the pelvis: CT and MRI findings. Magn Reson Imaging 1991;9:463-465
33. Bhagarva R, Parham DM, Lasater OE, et al. MR imaging differentiation of benign and malignant peripheral nerve sheath tumours: use of the target sign. Pediatr Radiol 1997;27:124-129
34. Mc Laughlin ME, Jacks T. . Progesterone receptor expression in neurofibromas. Cancer 2003;63:752-755
35. Packer RJ, Guttmann DH, Rubenstein A, et al. Plexiform neurofibromas in N1: toward biologic-based therapy. Neurology 2002;58:1461-1470
36. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumours in neurofibromatosis 1. Cancer Res 2002;62:1573-1577
37. D'Agostino AN, Soule EH, Miller RH. Primary malignant neoplasms of nerves (malignant neurilemomas) in patients without manifestations if multiple neurofibromatosis (von Recklinghausen disease). Cancer 1963;16:1003-1014
38. Hartley N, Rajesh A, Verma R, et al. Abdominal manifestations of neurofibromatosis. J Comput Assist Tomogr 2008;32: 4-8.
39. Hammond JA, Driedger AA. Detection of malignant change in neurofibromatosis (von Recklinghausen disease) by gallium-67 scanning. Can Med Assoc J 1978;119:352-353
40. Evans DG, Baser ME, McGaughran J, et al. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002;39:311-314
41. Ducatman BS, Sheithauer BW, Piepgras DG, et al. Malignant peripheral nerve sheath tumours: a clinical pathological study of 120 cases. Cancer 1986;57:2006-2021
42. Irvin GL, Fishman LW, Sher JA. Familial pheochromocytoma. Surgery 1983;94:938-940
43. Walther MM, Herring J, Enquist E, et al. von Reckling-hausen disease and pheochromocytomas. J Urol 1999;162:1582-1586
44. Chetty R, Duhig JD. Bilateral pheochromocytoma-ganglioneuroma of the adrenal in type 1 neurofibromatosis. Am J Surg Pathol 1993;17:837-841
45. Teramoto S, Ota T, Maniwa A, et al. Two von Reckling-hausen disease cases with pheochromocytomas and gastrointestinal stromal tumours (GIST) in combination. Int J Urol 2007;14:73-74
46. Boldorini R, Tosoni A, Leutner M, et al. Multiple small intestinal stromal tumours in a patient with previously unrecognised neurofibromatosis type 1: immunohistochemical and ultrastructural evaluation. Pathology 2001;33:390-395
47. Miettinen M, Kopczynski J, Makhulouf HR, et al. Gastrointestinal stromal tumours, intramural leiomyomas and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, andmolecular genetic study of 167 cases.AmJ Surg Pathol 2003;27: 625-641
48. Ghrist TD. Gastrointestinal involvement in neurofibromatosis. Arch Intern Med 1963;112:357-362
49. Mietttinem M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumours in patients with neurofibromatosis 1. A clinicopathological and molecular genetic study of 45 cases. Am J Surg Pathol 2006;30:90-96
50. Kinoshita K, Hirota S, Isozaki K, et al. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol 2004;202:80-85
51. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003;299:278.
52. Stewart DR, Coreless CL, Rubin BP, et al. Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1. J Med Genet 2007;44:61.
53. Kramer K, Hasel C, Aschoff JA, et al. Multiple gastrointestinal stromal tumours and bilateral pheochromocytoma in neurofibromatosis. World J Gastroenterol 2007;13:3384-3387
54. Levy AD, Patel N, Abbott RM, et al. Gastrointestinal stromal tumours in patients with neurofibromatosis: imaging features with clinicopathologic correlation. AJR Am J Roentgenol 2004; 183:1629-1635
55. Kalender ME, Seviniv A, Tutar E, et al. Effect of sunitinib on metastatic gastrointestinal stromal tumour in patients with neurofibromatosis type 1: a case report. World J Gastroenterol 2007;13:2629-2632